ReviewFrontiers in pharmacology2024

Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future.

Harriet Lampe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.